Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2010-04-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-010-0855-8PMID 20414655PMCID PMC3706261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

  2010influential reference
• Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation

  2009cited by this paper
• Inflammation enhances myeloid‐derived suppressor cell cross‐talk by signaling through Toll‐like receptor 4

  2009cited by this paper
• Mast cells as target in cancer therapy.

  2009cited by this paper
• Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells1

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells.

  2008cited by this paper
• Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1

  2008cited by this paper
• Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.

  2008cited by this paper
• Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.

  2008cited by this paper
• Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.

  2008cited by this paper
• Regulatory T cells and treatment of cancer.

  2008cited by this paper
• Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.

  2008cited by this paper
• Modulation of the anti-tumor immune response by complement

  2008cited by this paper
• NKT Cells in Tumor Immunity: Opposing Subsets Define a New Immunoregulatory Axis1

  2008cited by this paper
• Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells1

  2008cited by this paper
• Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

  2008cited by this paper
• Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives

  2008cited by this paper
• The thiol redox state of lymphoid organs is modified by immunization: Role of different immune cell populations

  2008cited by this paper
• Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

  2008cited by this paper
• The terminology issue for myeloid-derived suppressor cells.

  2007cited by this paper
• Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

  2007cited by this paper
• Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response1

  2007cited by this paper
• MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis

  2007cited by this paper
• Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.

  2007cited by this paper
• Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host.

  2007cited by this paper
• CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.

  2007cited by this paper
• L-arginine availability regulates T-lymphocyte cell-cycle progression.

  2007cited by this paper
• HIF-dependent antitumorigenic effect of antioxidants in vivo.

  2007cited by this paper
• Expression and function of cystine/glutamate transporter in neutrophils

  2007influential reference
• CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis1

  2007cited by this paper
• Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.

  2007influential reference
• TCR ζ Down-Regulation under Chronic Inflammation Is Mediated by Myeloid Suppressor Cells Differentially Distributed between Various Lymphatic Organs1

  2006cited by this paper
• Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression1

  2006cited by this paper
• ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding.

  2006cited by this paper
• All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

  2006cited by this paper
• Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.

  2006cited by this paper
• CD11b+/Gr-1+ Myeloid Suppressor Cells Cause T Cell Dysfunction after Traumatic Stress1

  2006cited by this paper
• Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

  2006cited by this paper
• A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

  2005cited by this paper
• Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

  2005cited by this paper
• Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.

  2005cited by this paper
• Reactive Oxygen Species and 12/15-Lipoxygenase Contribute to the Antiproliferative Capacity of Alternatively Activated Myeloid Cells Elicited during Helminth Infection 1

  2005cited by this paper
• Reactive Oxygen Species and 12/15-Lipoxygenase Contribute to the Antiproliferative Capacity of Alternatively Activated Myeloid Cells Elicited during Helminth Infection

  2005cited by this paper
• Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease1

  2005cited by this paper
• CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells1

  2005cited by this paper
• Regulation of immune responses by L-arginine metabolism

  2005cited by this paper
• Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

  2005cited by this paper
• Mechanisms and functional significance of tumour-induced dendritic-cell defects

  2004cited by this paper
• Ligands for L-selectin: homing, inflammation, and beyond.

  2004cited by this paper
• Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression.

  2004cited by this paper
• A prospective study of plasma total cysteine and risk of breast cancer.

  2003cited by this paper
• All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

  2003cited by this paper
• L-Selectin Ligands in Lymphoid Tissues and Models of Inflammation

  2003cited by this paper
• Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

  2002cited by this paper
• Regulation of T Cell Receptor CD3ζ Chain Expression byl-Arginine*

  2002cited by this paper
• Regulation of T cell receptor CD3zeta chain expression by L-arginine.

  2002cited by this paper
• Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug

  2001cited by this paper
• Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1

  2001cited by this paper
• Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice.

  2000cited by this paper
• Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

  2000cited by this paper
• Physiological functions of thioredoxin and thioredoxin reductase.

  2000cited by this paper
• L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites

  1995cited by this paper
• Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.

  1995cited by this paper
• Entry of naive CD4 T cells into peripheral lymph nodes requires L- selectin

  1994cited by this paper
• Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma.

  1992cited by this paper
• Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasi

  1992cited by this paper
• Neutral amino acid transport in mouse peritoneal macrophages.

  1987cited by this paper
• Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships.

  1984cited by this paper
• Transport of cystine and cysteine in mammalian cells.

  1984cited by this paper
• Transforming Growth Factor-␤ Production and Myeloid Cells Are an Effector Mechanism through Which Cd1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance: Abrogation Prevents Tumor Recurrence

  year unknowninfluential reference

• Neoantigen-Encoded Oncolytic Viruses as Personalized Cancer Vaccines

  2026cites this paper
• Biliary stents can modify the microbiota and promote the progression of pancreatic cancer

  2026cites this paper
• HypoxamiRs in pancreatic cancer: master regulators of the hypoxic tumor microenvironment

  2025cites this paper
• Novel bioengineered drugs with immunotherapies for malignant pleural effusion: remodulate tumor immune microenvironment and activate immune system.

  2025cites this paper
• Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments

  2025cites this paper
• Bardoxolone Methyl: A Comprehensive Review of Its Role as a Nrf2 Activator in Anticancer Therapeutic Applications

  2025cites this paper
• Eleutheroside A inhibits PI3K/AKT1/mTOR-mediated glycolysis in MDSCs to alleviate their immunosuppressive function in gastric cancer.

  2025cites this paper
• Iron metabolism and the tumor microenvironment: A new perspective on cancer intervention and therapy (Review)

  2024cites this paper
• Evasion of the Immune System by Glioblastoma Multiforme: An Obstacle to Achieving Effective Therapies

  2024cites this paper
• Pre-metastatic niche: formation, characteristics and therapeutic implication

  2024cites this paper
• Cryoablation synergizes with anti-PD-1 immunotherapy induces an effective abscopal effect in murine model of cervical cancer

  2024cites this paper
• Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications

  2024cites this paper
• Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives.

  2024cites this paper
• Genetics and biology of pancreatic ductal adenocarcinoma

  2024cites this paper
• Depletion of monocytic myeloid-derived suppressor cells in LP-BM5 murine retroviral infection has a positive impact on virus-induced host immunodeficiency.

  2024cites this paper
• Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression

  2024cites this paper
• Manipulating host secreted protein gene expression: an indirect approach by HPV11/16 E6/E7 to suppress PBMC cytokine secretion

  2024cites this paper
• 5-Fluorouracil Effectively Depletes Tumor Induced Myeloid Derived Suppressor Cells in 4T1 Mammary Carcinoma Model

  2024cites this paper
• POI-SIMEX for Conditionally Poisson Distributed Biomarkers from Tissue Histology

  2024cites this paper
• Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice

  2024cites this paper
• Exploring Immune Redox Modulation in Bacterial Infections: Insights into Thioredoxin-Mediated Interactions and Implications for Understanding Host–Pathogen Dynamics

  2024cites this paper
• Mechanisms of HIF1A-mediated immune evasion in gastric cancer and the impact on therapy resistance

  2024cites this paper
• EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells

  2024cites this paper
• Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy

  2024cites this paper
• Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients

  2023cites this paper
• Radiotherapy Combination: Insight from Tumor Immune Microenvironment (TIME)

  2023cites this paper
• Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice

  2023cites this paper
• Bacterial Magnetosome‐Hitchhiked Quick‐Frozen Neutrophils for Targeted Destruction of Pre‐Metastatic Niche and Prevention of Tumor Metastasis

  2023cites this paper
• Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b+/Gr-1+ myeloid cells depletion using a recombinant peptibody in 4 T1-HER2 tumor model.

  2023cites this paper
• Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma

  2023cites this paper
• S100A8/A9-RAGE pathway and chronic airway inflammation in smoke-induced lung carcinogenesis

  2023cites this paper
• Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.

  2023cites this paper
• 5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity

  2023cites this paper
• POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma

  2023cites this paper
• Combining Cryo-Thermal Therapy with Anti-IL-6 Treatment Promoted the Maturation of MDSCs to Induce Long-Term Survival in a Mouse Model of Breast Cancer

  2023cites this paper
• Proteomic investigation and biomarker identification of lung and spleen deficiency syndrome in HIV/AIDS immunological nonresponders

  2023cites this paper
• NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells.

  2023cites this paper
• Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations

  2023cites this paper
• Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors

  2023cites this paper
• The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma

  2023influential citation
• Cancer-cell-intrinsic mechanisms regulate MDSCs through cytokine networks.

  2023cites this paper
• Gene Polymorphisms and Biological Effects of Vitamin D Receptor on Nonalcoholic Fatty Liver Disease Development and Progression

  2023cites this paper
• Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer

  2023cites this paper
• Exosomes Derived From Dendritic Cells Infected With Toxoplasma gondii Show Antitumoral Activity in a Mouse Model of Colorectal Cancer

  2022cites this paper
• Myeloid Derived Suppressor Cells Migrate in Response to Flow and Lymphatic Endothelial Cell Interaction in the Breast Tumor Microenvironment

  2022cites this paper
• Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer

  2022cites this paper
• The evolution of immune dysfunction in multiple myeloma

  2022cites this paper
• Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy

  2022cites this paper
• Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy

  2022cites this paper
• Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment

  2022cites this paper
• Intrinsic and acquired cancer immunotherapy resistance

  2022cites this paper
• Targeted delivery and reprogramming of myeloid-derived suppressor cells (MDSCs) in cancer

  2022cites this paper
• Epigenetic programming of the immune responses in cancer

  2022cites this paper
• Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1

  2022cites this paper
• Metformin as a Potential Antitumor Agent

  2022cites this paper
• Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities

  2022cites this paper
• Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors

  2022cites this paper
• Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota.

  2022cites this paper
• Effect of Angelica polysaccharide on mouse myeloid-derived suppressor cells

  2022cites this paper
• Immune Tumor Microenvironment in Ovarian Cancer Ascites

  2022influential citation
• Cloning, expression and characterization of a peptibody to deplete myeloid derived suppressor cells in a murine mammary carcinoma model.

  2021cites this paper
• Assessment of sarcopenia as a predictor of poor overall survival for advanced non-small-cell lung cancer patients receiving salvage anti-PD-1 immunotherapy

  2021cites this paper
• Myeloid-Derived Suppressive Cells in Ageing and Age-Related Diseases

  2021cites this paper
• Review: Challenges of In Vitro CAF Modelling in Liver Cancers

  2021cites this paper
• Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells

  2021cites this paper
• Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression

  2021cites this paper
• A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment

  2021cites this paper
• Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor

  2021cites this paper
• ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

  2021influential citation
• Development of an Interferon Gamma Response-Related Signature for Prediction of Survival in Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Roles of CCL2-CCR2 Axis in the Tumor Microenvironment

  2021cites this paper
• Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19

  2021cites this paper
• Myeloid-Derived Suppressor Cells in Trypanosoma cruzi Infection

  2021cites this paper
• Plant Science Today

  2021cites this paper
• Engineered immune cells with nanomaterials to improve adoptive cell therapy

  2021cites this paper
• Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices

  2021cites this paper
• Hydrogel/nanoadjuvant-mediated Combined Cell Vaccines for Cancer Immunotherapy.

  2021cites this paper
• Metabolic reprogramming of myeloid‐derived suppressor cells: An innovative approach confronting challenges

  2021cites this paper
• The impact of microRNAs on myeloid-derived suppressor cells in cancer.

  2021cites this paper
• Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models

  2021cites this paper
• PD-1 blockade combined with IL-33 enhances the antitumor immune response in a type-1 lymphocyte-mediated manner.

  2021cites this paper
• Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome

  2021cites this paper
• Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to Mycobacterium tuberculosis

  2021cites this paper
• SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells

  2021cites this paper
• Bacterial-driven inflammation and mutant BRAF expression combine to promote murine colon tumorigenesis that is sensitive to immune checkpoint therapy.

  2021cites this paper
• Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers

  2021cites this paper
• Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth

  2021cites this paper
• Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT

  2021cites this paper
• Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients

  2021cites this paper
• How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer

  2021cites this paper
• Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.

  2021cites this paper
• Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?

  2021cites this paper
• Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy

  2021cites this paper
• HDAC11 regulates expression of C/EBPβ and immunosuppressive molecules in myeloid‐derived suppressor cells

  2021cites this paper
• The Involvement of Macrophage Colony Stimulating Factor on Protein Hydrolysate Injection Mediated Hematopoietic Function Improvement

  2021influential citation
• Repression of MUC1 promotes expansion and suppressive function of myeloid-derived suppressor cells in pancreatic ductal adenocarcinoma and breast cancer murine models

  2020cites this paper
• AhR Activation Leads to Alterations in the Gut Microbiome with Consequent Effect on Induction of Myeloid Derived Suppressor Cells in a CXCR2-Dependent Manner

  2020cites this paper
• Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non‐small cell lung cancer

  2020cites this paper
• Targeting Inhibitory Cells Such as Tregs and MDSCs in the Tuberculous Granuloma

  2020cites this paper
• Role of the Cyclooxygenase Pathway in the Association of Obstructive Sleep Apnea and Cancer

  2020cites this paper